Skip to main content

Publisher: Bentham Science Publishers

Volume 11, Number 3, March 2010

Articles

CDK Inhibitors: From the Bench to Clinical Trials
pp. 279-290(12)
Authors: Rizzolio, Flavio; Tuccinardi, Tiziano; Caligiuri, Isabella; Lucchetti, Chiara; Giordano, Antonio

Favourites:
ADD

Cyclin-Dependent Kinase Inhibitors as Anticancer Drugs
pp. 291-302(12)
Authors: Krystof, Vladimir; Uldrijan, Stjepan

Favourites:
ADD

Halogen Atoms in the Modern Medicinal Chemistry: Hints for the Drug Design
pp. 303-314(12)
Authors: Hernandes, Marcelo Z.; Cavalcanti, Suellen Melo T.; Moreira, Diogo Rodrigo M.; de Azevedo Junior, Walter Filgueira; Leite, Ana Cristina Lima

Favourites:
ADD
Favourites:
ADD

MolDock Applied to Structure-Based Virtual Screening
pp. 327-334(8)
Author: De Azevedo Jr., Walter F.

Favourites:
ADD

Z-DNA Binding Proteins as Targets for Structure-Based Virtual Screening
pp. 335-344(10)
Authors: Kim, Doyoun; Lee, Young -Ho; Hwang, Hye-Yeon; Kim, Kyeong K.; Park, Hyun-Ju

Favourites:
ADD

Future Prospect of RNA Interference for Cancer Therapies
pp. 345-360(16)
Authors: Ashihara, Eishi; Kawata, Eri; Maekawa, Taira

Favourites:
ADD

Valproic Acid in the Complex Therapy of Malignant Tumors
pp. 361-379(19)
Authors: Hrebackova, J.; Hrabeta, J.; Eckschlager, T.

Favourites:
ADD

Advances in Antiplatelet Therapy for Stroke Prevention: the New P2Y12 antagonists
pp. 380-391(12)
Authors: Giossi, A.; Pezzini, A.; Zotto, E. D.; Volonghi, I.; Costa, P.; Ferrari, D.; Padovani, A.

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more